

[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - WOPRAI
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
[ Wed, Oct 19th 2011
] - Market Wire
Los datos sobre el uso temprano y los beneficios a largo plazo de TYSABRI han sido presentados en el 5 congreso trienal conjun
WESTON, Massachussets & DUBLIN--([ BUSINESS WIRE ])--[ Biogen Idec ] (NASDAQ: BIIB) y [ Elan Corporation, plc ](NYSE: ELN) han anunciado las 28 presentaciones de la empresa sobre TYSABRI? (natalizumab) durante el 5? congreso trienal conjunto de los comit?s europeos y americanos para el tratamiento e investigaci?n de la esclerosis m?ltiple (ECTRIMS y ACTRIMS), celebrado en ?msterdam (Holanda).
El comunicado en el idioma original, es la versi?n oficial y autorizada del mismo. La traducci?n es solamente un medio de ayuda y?deber? ser?comparada con el texto en idioma original, que es la ?nica versi?n del texto que tendr? validez legal.